Richard Dirven

The Netherlands Cancer Institute

Papers

1

Total Citations

2

H-Index

1

About

Richard Dirven is a clinical researcher whose work centers on shared decision-making in head and neck oncology, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC). His major contribution lies in the development of a pioneering interactive online patient decision aid (PDA) for patients eligible for transoral robotic surgery. This tool, detailed in his 2023 mixed-methods study, is designed to bridge the gap between complex surgical options and patient understanding, empowering both clinicians and patients to make more informed, collaborative treatment choices. While his most-cited paper is early in its citation lifecycle, its practical, patient-centered approach signals a significant shift toward integrating decision support tools into routine oncologic care. Dirven’s work is notable for its rigorous methodology, combining qualitative patient insights with quantitative clinical data, and for addressing a critical need in a field where treatment decisions carry profound quality-of-life implications. His research is poised to influence how multidisciplinary teams communicate risk and benefit, ultimately enhancing patient autonomy and outcomes in head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago